Literature DB >> 22326144

Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents.

Li Pan1, Ying Jiang, Zhen Liu, Xing-Hai Liu, Zhuo Liu, Gang Wang, Zheng-Ming Li, Di Wang.   

Abstract

A series of novel monosubstituted sulfonylurea derivatives 10a-y were synthesized and characterized by (1)H NMR, (13)C NMR and HRMS. These compounds were evaluated against Mycobacterium tuberculosis H37Rv in vitro. The results showed compounds 10f, 10k and 10s exhibited moderate antituberculosis activities with MIC values in the range of 20-100 mg/L. Compounds 10b and 10o displayed good antituberculosis activities (MIC 10 mg/L), which were comparable with that of the sulfometuron methyl. Both of the two compounds showed little cytotoxicities, with an IC(50) against THP-1 cells greater than 100 mg/L. Copyright Â
© 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326144     DOI: 10.1016/j.ejmech.2012.01.011

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Synthesis, Herbicidal Activity, Crop Safety and Soil Degradation of Pyrimidine- and Triazine-Substituted Chlorsulfuron Derivatives.

Authors:  Lei Wu; Yu-Cheng Gu; Yong-Hong Li; Sha Zhou; Zhong-Wen Wang; Zheng-Ming Li
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

2.  Research on the controllable degradation of N-methylamido and dialkylamino substituted at the 5th position of the benzene ring in chlorsulfuron in acidic soil.

Authors:  Fan-Fei Meng; Lei Wu; Yu-Cheng Gu; Sha Zhou; Yong-Hong Li; Ming-Gui Chen; Shaa Zhou; Yang-Yang Zhao; Yi Ma; Zheng-Ming Li
Journal:  RSC Adv       Date:  2020-05-07       Impact factor: 3.361

3.  Synthesis and oral hypoglycemic effect of novel thiazine containing trisubstituted benzenesulfonylurea derivatives.

Authors:  Alok Singh Thakur; Ravitas Deshmukh; Arvind Kumar Jha; P Sudhir Kumar
Journal:  Saudi Pharm J       Date:  2014-12-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.